cbdMD, Inc.YCBDEarnings & Financial Report
cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.
YCBD Q1 FY2026 Key Financial Metrics
Revenue
$5.0M
Gross Profit
$3.0M
Operating Profit
$-286.3K
Net Profit
$-283.1K
Gross Margin
59.8%
Operating Margin
-5.7%
Net Margin
-5.6%
YoY Growth
-1.9%
EPS
$-0.04
cbdMD, Inc. Q1 FY2026 Financial Summary
cbdMD, Inc. reported revenue of $5.0M (down 1.9% YoY) for Q1 FY2026, with a net profit of $-283.1K (down 1975.7% YoY) (-5.6% margin). Cost of goods sold was $2.0M, operating expenses totaled $3.3M.
Key Financial Metrics
| Total Revenue | $5.0M |
|---|---|
| Net Profit | $-283.1K |
| Gross Margin | 59.8% |
| Operating Margin | -5.7% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
cbdMD, Inc. Q1 FY2026 revenue of $5.0M breaks down across 2 segments, led by Sales Channel Directly To Consumer at $3.6M (71.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Sales Channel Directly To Consumer | $3.6M | 71.8% |
| Sales Channel Through Intermediary | $1.4M | 28.2% |
cbdMD, Inc. Revenue by Segment — Quarterly Trend
cbdMD, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Sales Channel Directly To Consumer and Sales Channel Through Intermediary) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Sales Channel Directly To Consumer | $3.6M | $3.5M | $3.6M | $3.6M |
| Sales Channel Through Intermediary | $1.4M | $1.2M | $1.0M | $1.1M |
cbdMD, Inc. Annual Revenue by Year
cbdMD, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $19.2M).
cbdMD, Inc. Quarterly Revenue & Net Profit History
cbdMD, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $5.0M | -1.9% | $-283.1K | -5.6% |
| Q4 FY2025 | $4.7M | +3.6% | $-680.0K | -14.4% |
| Q3 FY2025 | $4.6M | -11.0% | $-895.3K | -19.4% |
| Q2 FY2025 | $4.7M | +8.5% | $-480.8K | -10.1% |
| Q1 FY2025 | $5.1M | -4.9% | $15.1K | 0.3% |
| Q4 FY2024 | $4.6M | -20.2% | $-152.8K | -3.4% |
| Q3 FY2024 | $5.2M | -15.5% | $459.7K | 8.9% |
| Q2 FY2024 | $4.4M | -29.9% | $-3.0M | -68.8% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4M | $5.2M | $4.6M | $5.1M | $4.7M | $4.6M | $4.7M | $5.0M |
| YoY Growth | -29.9% | -15.5% | -20.2% | -4.9% | 8.5% | -11.0% | 3.6% | -1.9% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $14.6M | $13.8M | $10.6M | $11.5M | $10.9M | $9.9M | $10.4M | $11.8M |
| Liabilities | $11.5M | $10.8M | $8.6M | $9.8M | $10.3M | $3.8M | $3.2M | $2.8M |
| Equity | $3.1M | $3.0M | $2.0M | $1.8M | $665798 | $6.1M | $7.2M | $9.0M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-704068 | $289779 | $167377 | $-317949 | $-189477 | $-704200 | $-240749 | $-812464 |